We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VEND:EURONEXT OSLOVend Marketplaces ASA Analysis

Data as of 2026-06-06 - not real-time

NOK 253.20

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Vend Marketplaces trades around NOK 253, significantly above its DCF fair value of roughly NOK 123, indicating a material overvaluation despite a strong cash position of NOK 5.6 bn. Technical signals show a bearish price trend (price below the 20‑day and 50‑day SMAs and well under the 200‑day SMA) and a support level near NOK 236, while the MACD histogram is bullish but the overall trend remains negative. Fundamentally, the company posted modest revenue growth of 2% YoY and a 36% EBITDA increase, yet it still reports a negative profit margin and a -16.8% ROE, underscoring earnings volatility. The dividend yield of 0.99% is supported by a low payout ratio and ample liquidity, but the sustainability hinges on turning the profitability curve around. Recent Q1 2026 earnings calls highlighted margin expansion and cash‑flow generation, offering a glimpse of operational improvement that could justify the current forward EPS expectations. Given the extreme greed sentiment in the market (Fear & Greed Index 83) and a high 30‑day volatility of over 41%, investors should weigh the upside potential against the valuation gap and technical weakness.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price well above DCF fair value
  • Bearish technical trend and proximity to support
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Improving EBITDA and margin expansion reported in Q1 2026
  • Stable dividend with low payout ratio
  • Strong cash balance offsetting earnings weakness

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic market position across Nordic classifieds
  • Potential for sustained earnings turnaround and higher forward EPS
  • Low beta indicating defensive characteristics in a growth‑oriented business

Key Metrics & Analysis

Financial Health

Revenue Growth1.60%
Profit Margin-42.24%
P/E Ratio24.8
ROE-16.82%
ROA3.52%
Debt/Equity15.70
P/B Ratio2.2
Op. Cash FlowNOK2.0B
Free Cash FlowNOK1.6B
Industry P/E17.0

Technical Analysis

TrendBearish
RSI57.9
SupportNOK 236.00
ResistanceNOK 262.80
MA 20NOK 244.52
MA 50NOK 245.71
MA 200NOK 288.81
MACDBullish
VolumeStable
Fear & Greed Index83.02

Valuation

Fair ValueNOK 123.15
Target PriceNOK 302.43
Upside/Downside19.44%
GradeOvervalued
TypeGrowth
Dividend Yield0.99%

Risk Assessment

Beta0.37
Volatility41.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.